Krsnaa Diagnostics Board of Directors

Get the latest insights into the leadership at Krsnaa Diagnostics. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Rajendra Mutha Chairperson & Executive Director
Ms. Pallavi Bhatevara Executive Director
Mr. Yash Mutha Executive Director
Mr. Adesh Kumar Gupta Ind. Non-Executive Director
Mr. Rajiva Ranjan Verma Ind. Non-Executive Director
Mr. Chetan Desai Ind. Non-Executive Director
Ms. Chhaya Palrecha Ind. Non-Executive Director
Mr. Prem Pradeep Non Exe. & Nominee Director

Krsnaa Diagnostics Share price

KRSNAA

830.45

25.55 (3.17%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:42 IST
BUYSELL
Today's High

850.00

Today's Low

806.25

52 Week Low

625.75

52 Week High

1044.00

The current prices are delayed, login to your account for live prices

Krsnaa Diagnostics FAQs

The board at Krsnaa Diagnostics consists of experienced professionals, including Mr. Rajendra Mutha , Ms. Pallavi Bhatevara , and others, overseeing the company’s strategic and corporate governance.

Directors at Krsnaa Diagnostics are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Rajendra Mutha is the current chairman at Krsnaa Diagnostics.

Executive directors at Krsnaa Diagnostics are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Krsnaa Diagnostics adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Krsnaa Diagnostics, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.